Keyword | CPC | PCC | Volume | Score | Length of keyword |
---|---|---|---|---|---|
insulin glargine peak effect | 0.04 | 0.2 | 3314 | 53 | 28 |
insulin | 0.5 | 0.8 | 5450 | 28 | 7 |
glargine | 1.11 | 0.1 | 4024 | 8 | 8 |
peak | 1.05 | 0.7 | 6915 | 33 | 4 |
effect | 1.68 | 0.9 | 2058 | 68 | 6 |
Keyword | CPC | PCC | Volume | Score |
---|---|---|---|---|
insulin glargine peak effect | 1.99 | 0.5 | 2316 | 21 |
peak of insulin glargine | 1.52 | 0.6 | 8246 | 11 |
glargine insulin peak action | 1.82 | 0.9 | 9445 | 61 |
glargine insulin peak and duration | 0.69 | 0.1 | 6594 | 22 |
insulin glargine peak and onset | 1.93 | 0.4 | 6775 | 63 |
glargine insulin peak time | 1.99 | 1 | 2523 | 79 |
peak effect of glargine | 0.33 | 0.7 | 107 | 9 |
when does glargine insulin peak | 0.07 | 0.3 | 5180 | 21 |
insulin glargine onset peak and duration | 1.19 | 0.6 | 2244 | 29 |
glargine insulin onset peak duration | 1.43 | 0.5 | 5863 | 21 |
insulin glargine therapeutic effect | 0.89 | 0.2 | 9225 | 6 |
insulin glargine dose increase | 1.23 | 0.8 | 4931 | 83 |
glargine long acting insulin | 1 | 0.6 | 5871 | 8 |
glargine insulin onset of action | 0.88 | 0.7 | 612 | 45 |
Insulin glargine is a long-acting insulin that starts to work several hours after injection and keeps working evenly for 24 hours. Insulin glargine is used to improve blood sugar control in people with diabetes mellitus. Toujeo is for use in adults with type 1 or type 2 diabetes.
What are the benefits of using insulin glargine?Insulin glargine is a synthetic version of human insulin that is FDA approved to treat adults and children with type 1 diabetes and adults with type 2 diabetes to improve and maintain glycemic control. Insulin glargine is a long-acting insulin injected once daily and provides a basal insulin level throughout the day.
What is the duration of action of insulin glargine?Insulin glargine is a recombinant human insulin analogue that does provide 24-hour duration of action in most, but not all, patients with T1DM. It differs from human insulin in that the amino acid asparagine at position A21 is replaced by glycine, and two arginines are added to the carboxy (C)-terminus of the B chain.
How does insulin glargine compare to other types of insulin?Insulin glargine differs from human insulin by adding two arginines to the C-terminus of the B-chain in addition to containing glycine at position A21 in comparison to the asparagine found in human insulin. Insulins are categorized based on the onset, peak, and duration of effect (eg, rapid-, short-, intermediate-, and long-acting insulin).